Griffin v. Foley

542 F.3d 209, 71 Fed. R. Serv. 3d 826, 2008 U.S. App. LEXIS 18919, 2008 WL 4072822
CourtCourt of Appeals for the Seventh Circuit
DecidedSeptember 4, 2008
Docket07-2689
StatusPublished
Cited by84 cases

This text of 542 F.3d 209 (Griffin v. Foley) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Griffin v. Foley, 542 F.3d 209, 71 Fed. R. Serv. 3d 826, 2008 U.S. App. LEXIS 18919, 2008 WL 4072822 (7th Cir. 2008).

Opinion

MANION, Circuit Judge.

As a result of a car accident, Lisa Griffin had to undergo back surgery, which Dr. Robert Foley performed. After complications arose from the surgery, Lisa and her husband Michael filed this diversity suit against Foley in the district court alleging medical malpractice. The case went to *212 trial, and a jury returned a verdict in favor of Foley. The Griffins appeal, raising several challenges to the trial court’s procedural handling of their case. We affirm.

I.

On June 11, 1994, while traveling through Georgia, the Griffins’ minivan was struck in the rear by a pickup truck. As a result of the collision, Lisa Griffin (“Lisa”) sustained severe injuries, including a burst fracture 1 at the LI vertebra. Lisa was flown to Evansville, Indiana, where, on June 14, 1994, orthopedic surgeon Dr. Robert Foley performed both a laminecto-my 2 and a spinal fusion on her back. During the operation, Foley used an internal fixation device consisting of rods and hooks to keep Lisa’s back in place. He then combined the bone he took from Lisa’s lamina with coralline hydroxyapa-tite, a bone graft substitute made of coral reef that goes by the trade name Pro Osteon. Although the Food and Drug Administration had approved Pro Osteon as a bone graft substitute to fill holes in bone, the FDA had not specifically approved it for use as a bone graft extender in spinal fusions. Foley placed the mixture at the fracture site as a bone graft and completed the surgery.

Foley continued to see Lisa in follow-up visits after the surgery. While at trial the parties disputed the relative success of the surgery, it was undisputed that, in October 1994, x-rays of Lisa’s back showed increased kyphosis 3 in her spine, a recognized complication of spinal fusion surgery. The kyphosis made the rods and hooks from the fixation device conspicuous underneath her skin, so on May 16, 1995, Foley performed a second surgery on Lisa to remove the internal fixation device. However, a later x-ray taken in March 1996 showed further kyphosis in Lisa’s spine. At this point, Foley recommended additional surgery — the parties disputed the nature of the surgery recommended' — ■ which Lisa declined. Later on, the failure of the back fusion to achieve a union (another recognized complication of fusion surgery) became evident. When Foley ought to have been aware of that fact and how he should have reacted were vigorously contested at trial. As a result of her back, Lisa is now permanently disabled and unable to work.

The Griffins initiated this medical malpractice suit against Foley on June 11, 1998. Pursuant to Indiana law, 4 they first filed a proposed complaint with the Indiana Department of Insurance alleging that Foley was negligent because, among other things, he used Pro Osteon as a bone graft substitute in Lisa’s spine surgery when it was not FDA-approved for that use and had no therapeutic benefit as a bone graft substitute in spinal fusion surgery. The Department of Insurance assembled a medical review panel to review the case. 5 After the case languished be *213 fore the panel for over six years, the panel issued a one-sentence opinion: “The evidence does not support the conclusion that the defendant failed to meet the applicable standard of care as charged in the complaint.” 6

The Griffins then took their case to federal court in January 2005. Trial was scheduled for October 10, 2006, and the case management plan approved by both parties and the district court gave the Griffins until April 18, 2006, and Foley 60 days thereafter, to submit the expert witness reports required by Federal Rule of Civil Procedure 26. 7 On April 18, 2006, the Griffins filed Rule 26 reports for their experts: Dr. Lawrence Weis, Dr. Robert Lieberson, Dr. Timothy Lalk, and Professor John Navin. After the Griffins filed their expert witness reports, Foley noticed Navin’s deposition for April 28, 2006. Three days prior to the deposition, the Griffins’ counsel served notice that he would be videotaping Navin’s deposition for purposes of trial. 8 In response, Foley filed a motion for a protective order seeking to preserve the opportunity to cross-examine Navin for purposes of trial at a later date. In that motion, Foley asserted that the Griffins’ counsel had refused to produce Navin at a later date to allow the defense to cross-examine him for purposes of trial. The magistrate judge assigned to the case granted Foley’s motion, stating in its order that Navin must appear for his previously noticed discovery deposition and that, thereafter, the parties were free to examine or cross-examine Navin at a later date for purposes of eliciting trial testimony. The order also stated that Foley was entitled to cross-examine the Griffins’ other experts prior to trial after taking their discovery depositions. In a later order expounding on its reasons for granting the motion, the magistrate judge stated that it was “reasonable to allow some period of time between discovery of all the information used by an expert and the preparation of cross-examination for trial.” 9

Foley then proceeded to take depositions of the Griffins’ retained experts for discovery purposes. The Griffins’ counsel provided notice that the evidentiary depositions of Navin, Weis, and Lalk would immediately follow their discovery depositions. When Foley’s counsel was finished *214 questioning in each of those three depositions, the Griffins’ counsel conducted a direct examination of the expert for use at trial. At a later date, Foley conducted a follow-up deposition with each of those three experts for purposes of evidentiary cross-examination before trial. At the beginning of Weis’s follow-up deposition for cross-examination, the Griffins’ counsel asked additional questions of Weis intended to supplement his direct examination, to which Foley’s counsel objected because the Griffins had already passed the witness.

On June 19, 2006, the defense submitted its Rule 26 expert disclosures, but did not include any Rule 26 reports from the members of the medical review panel. The Griffins then filed a motion for sanctions under Fed.R.Civ.P. 37 based, in part, on the absence of those Rule 26 reports. The magistrate judge concluded in an August 16, 2006, telephone conference that no sanctions were warranted and that there was good cause to extend the deadline for expert disclosures, though Foley would have to file Rule 26 reports from the members of the medical review panel he wished to call at trial.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Paula Emerson v. Thomas Dart
109 F.4th 936 (Seventh Circuit, 2024)
Stanford Clacks v. Kwik Trip, Incorporated
108 F.4th 950 (Seventh Circuit, 2024)
Antero Resources v. Kawcak
85 F.4th 741 (Fifth Circuit, 2023)
United States v. Gary Tinsley
Seventh Circuit, 2023
Shakur v. Swalls
S.D. Illinois, 2023
Jacinta Downing v. Abbott Laboratories
48 F.4th 793 (Seventh Circuit, 2022)
Smith v. Ziegler
S.D. Illinois, 2022
Anaya v. Birck
N.D. Illinois, 2022
Cobbs v. Jeffreys
S.D. Illinois, 2021
Jackson v. Mitchell
S.D. Illinois, 2021
Wilson v. Baldwin
S.D. Illinois, 2021
Cogdell v. Murphy
District of Columbia, 2021
Webster v. Bosecker
S.D. Illinois, 2021

Cite This Page — Counsel Stack

Bluebook (online)
542 F.3d 209, 71 Fed. R. Serv. 3d 826, 2008 U.S. App. LEXIS 18919, 2008 WL 4072822, Counsel Stack Legal Research, https://law.counselstack.com/opinion/griffin-v-foley-ca7-2008.